Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
QLB vs IINB for Inguinal Herniorrhaphy
NCT03007966Phase 2Completed
- Sponsor
- Wake Forest University Health Sciences
- Start
- Jan 2017
- Primary completion
- Feb 2018
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial (2 arms), sponsored by Wake Forest University Health Sciences. Primary endpoint: Post-operative Verbal Pain Score With Movement at 8 hours. Started Jan 2017; status: completed.
Beyond the preview
Go deeper on NCT03007966.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03007966.